Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial.

Lopez J, Powles T, Braiteh F, Siu LL, LoRusso P, Friedman CF, Balmanoukian AS, Gordon M, Yachnin J, Rottey S, Karydis I, Fisher GA, Schmidt M, Schuler M, Sullivan RJ, Burris HA, Galvao V, Henick BS, Dirix L, Jaeger D, Ott PA, Wong KM, Jerusalem G, Schiza A, Fong L, Steeghs N, Leidner RS, Rittmeyer A, Laurie SA, Gort E, Aljumaily R, Melero I, Sabado RL, Rhee I, Mancuso MR, Muller L, Fine GD, Yadav M, Kim L, Leveque VJP, Robert A, Darwish M, Qi T, Zhu J, Zhang J, Twomey P, Rao GK, Low DW, Petry C, Lo AA, Schartner JM, Delamarre L, Mellman I, Löwer M, Müller F, Derhovanessian E, Cortini A, Manning L, Maurus D, Brachtendorf S, Lörks V, Omokoko T, Godehardt E, Becker D, Hawner C, Wallrapp C, Albrecht C, Kröner C, Tadmor AD, Diekmann J, Vormehr M, Jork A, Paruzynski A, Lang M, Blake J, Hennig O, Kuhn AN, Sahin U, Türeci Ö, Camidge DR

Open source

DOI
10.1038/s41591-024-03334-7
Published
2025 Jan
Container
Nature medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41591-024-03334-7,
  title = {Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial.},
  author = {Lopez J and Powles T and Braiteh F and Siu LL and LoRusso P and Friedman CF and Balmanoukian AS and Gordon M and Yachnin J and Rottey S and Karydis I and Fisher GA and Schmidt M and Schuler M and Sullivan RJ and Burris HA and Galvao V and Henick BS and Dirix L and Jaeger D and Ott PA and Wong KM and Jerusalem G and Schiza A and Fong L and Steeghs N and Leidner RS and Rittmeyer A and Laurie SA and Gort E and Aljumaily R and Melero I and Sabado RL and Rhee I and Mancuso MR and Muller L and Fine GD and Yadav M and Kim L and Leveque VJP and Robert A and Darwish M and Qi T and Zhu J and Zhang J and Twomey P and Rao GK and Low DW and Petry C and Lo AA and Schartner JM and Delamarre L and Mellman I and Löwer M and Müller F and Derhovanessian E and Cortini A and Manning L and Maurus D and Brachtendorf S and Lörks V and Omokoko T and Godehardt E and Becker D and Hawner C and Wallrapp C and Albrecht C and Kröner C and Tadmor AD and Diekmann J and Vormehr M and Jork A and Paruzynski A and Lang M and Blake J and Hennig O and Kuhn AN and Sahin U and Türeci Ö and Camidge DR},
  year = {2025},
  journal = {Nature medicine},
  doi = {10.1038/s41591-024-03334-7},
  url = {https://doi.org/10.1038/s41591-024-03334-7}
}

RIS

TY  - JOUR
TI  - Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial.
AU  - Lopez J
AU  - Powles T
AU  - Braiteh F
AU  - Siu LL
AU  - LoRusso P
AU  - Friedman CF
AU  - Balmanoukian AS
AU  - Gordon M
AU  - Yachnin J
AU  - Rottey S
AU  - Karydis I
AU  - Fisher GA
AU  - Schmidt M
AU  - Schuler M
AU  - Sullivan RJ
AU  - Burris HA
AU  - Galvao V
AU  - Henick BS
AU  - Dirix L
AU  - Jaeger D
AU  - Ott PA
AU  - Wong KM
AU  - Jerusalem G
AU  - Schiza A
AU  - Fong L
AU  - Steeghs N
AU  - Leidner RS
AU  - Rittmeyer A
AU  - Laurie SA
AU  - Gort E
AU  - Aljumaily R
AU  - Melero I
AU  - Sabado RL
AU  - Rhee I
AU  - Mancuso MR
AU  - Muller L
AU  - Fine GD
AU  - Yadav M
AU  - Kim L
AU  - Leveque VJP
AU  - Robert A
AU  - Darwish M
AU  - Qi T
AU  - Zhu J
AU  - Zhang J
AU  - Twomey P
AU  - Rao GK
AU  - Low DW
AU  - Petry C
AU  - Lo AA
AU  - Schartner JM
AU  - Delamarre L
AU  - Mellman I
AU  - Löwer M
AU  - Müller F
AU  - Derhovanessian E
AU  - Cortini A
AU  - Manning L
AU  - Maurus D
AU  - Brachtendorf S
AU  - Lörks V
AU  - Omokoko T
AU  - Godehardt E
AU  - Becker D
AU  - Hawner C
AU  - Wallrapp C
AU  - Albrecht C
AU  - Kröner C
AU  - Tadmor AD
AU  - Diekmann J
AU  - Vormehr M
AU  - Jork A
AU  - Paruzynski A
AU  - Lang M
AU  - Blake J
AU  - Hennig O
AU  - Kuhn AN
AU  - Sahin U
AU  - Türeci Ö
AU  - Camidge DR
PY  - 2025
JO  - Nature medicine
DO  - 10.1038/s41591-024-03334-7
UR  - https://doi.org/10.1038/s41591-024-03334-7
ER  -

APA

J, L., T, P., F, B., LL, S., P, L., CF, F., AS, B., M, G., J, Y., S, R., I, K., GA, F., M, S., M, S., RJ, S., HA, B., V, G., BS, H., L, D., D, J., PA, O., KM, W., G, J., A, S., L, F., N, S., RS, L., A, R., SA, L., E, G., R, A., I, M., RL, S., I, R., MR, M., L, M., GD, F., M, Y., L, K., VJP, L., A, R., M, D., T, Q., J, Z., J, Z., P, T., GK, R., DW, L., C, P., AA, L., JM, S., L, D., I, M., M, L., F, M., E, D., A, C., L, M., D, M., S, B., V, L., T, O., E, G., D, B., C, H., C, W., C, A., C, K., AD, T., J, D., M, V., A, J., A, P., M, L., J, B., O, H., AN, K., U, S., Ö, T., & DR, C. (2025). Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial.. Nature medicine. https://doi.org/10.1038/s41591-024-03334-7

Source records